| 3D-Printed oral dosage forms: Mechanical properties, computational approaches and applications D Karalia, A Siamidi, V Karalis, M Vlachou Pharmaceutics 13 (9), 1401, 2021 | 41 | 2021 |
| A non-binary biopharmaceutical classification of drugs: the ABΓ system P Macheras, V Karalis International journal of pharmaceutics 464 (1-2), 85-90, 2014 | 36 | 2014 |
| A physiologically based approach for the estimation of recirculatory parameters V Karalis, A Dokoumetzidis, P Macheras Journal of Pharmacology and Experimental Therapeutics 308 (1), 198-205, 2004 | 15 | 2004 |
| A Retrospective Analysis to Investigate Contact Sensitization in Greek Population Using Classic and Machine Learning Techniques A Kyritsi, A Tagka, A Stratigos, M Pesli, P Lagiokapa, V Karalis Worldwide Congress on “Genetics, Geriatrics and Neurodegenerative Diseases …, 2022 | 1 | 2022 |
| A retrospective study on the evaluation of the symptoms, medications and improvement of the quality of life of patients undergoing robotic surgery for gastroesophageal reflux … SK Konstantinidou, P Kostaras, GE Anagnostopoulos, SL Markantonis, ... Experimental and Therapeutic Medicine 21 (2), 1-1, 2021 | 3 | 2021 |
| A Semi-Physiological Modeling & Simulation approach for guided decision making in R&D E Karatza, V Karalis Proceedings of the AAPS Annual Meeting and Exposition, Washington, DC, USA, 4-7, 2018 | 3 | 2018 |
| A Vector Theory of Assessing Clinical Trials: An Application to Bioequivalence VD Karalis Journal of Cardiovascular Development and Disease 11 (7), 185, 2024 | | 2024 |
| Acknowledgement to Referees for Pharmacology 2016 B Hutter-Schmid, C Humpel, A Sahni, ED Thomasson, R Shah, SK Sahni, ... Pharmacology 98 (5-6), 299-300, 2016 | | 2016 |
| An In Silico Approach toward the Appropriate Absorption Rate Metric in Bioequivalence VD Karalis Pharmaceuticals 16 (5), 725, 2023 | 3 | 2023 |
| An in vitro–in vivo simulation approach for the prediction of bioequivalence M Vlachou, V Karalis Materials 14 (3), 555, 2021 | 15 | 2021 |
| An In Vitro–In Vivo Simulation Approach for the Prediction of Bioequivalence. Materials 2021, 14, 555 M Vlachou, V Karalis s Note: MDPI stays neutral with regard to jurisdictional claims in published …, 2021 | | 2021 |
| An insight into the properties of a two-stage design in bioequivalence studies V Karalis, P Macheras Pharmaceutical research 30, 1824-1835, 2013 | 25 | 2013 |
| Analysis of Polysensitization and Monosensitization using Classic and Machine Learning Techniques A Kyritsi, A Tagka, A Stratigos, V Karalis Free Radical Biology and Medicine 201, 49-50, 2023 | | 2023 |
| Artificial intelligence in drug discovery and clinical practice VD Karalis From Current to Future Trends in Pharmaceutical Technology, 215-255, 2024 | | 2024 |
| Association of Antibiotic Use with the Resistance Epidemiology of Pseudomonas aeruginosa in a Hospital Setting: A Four-Year Retrospective Time Series Analysis R Kousovista, C Athanasiou, K Liaskonis, O Ivopoulou, V Karalis Scientia Pharmaceutica 89 (1), 13, 2021 | 6 | 2021 |
| Bioavailability and bioequivalence: focus on physiological factors and variability V Karalis, P Macheras, A Van Peer, VP Shah Pharmaceutical research 25, 1956-1962, 2008 | 81 | 2008 |
| Bioequivalence of highly variable drugs: a comparison of the newly proposed regulatory approaches by FDA and EMA V Karalis, M Symillides, P Macheras Pharmaceutical research 29, 1066-1077, 2012 | 72 | 2012 |
| Bioequivalence studies in Europe before and after 2010 C Daousani, V Karalis Clinical Research and Regulatory Affairs 32 (1), 9-21, 2015 | | 2015 |
| Bioequivalence Studies of Highly Variable Drugs: An Old Problem Addressed by Artificial Neural Networks D Papadopoulos, G Karali, VD Karalis Applied Sciences 14 (12), 5279, 2024 | | 2024 |
| Biophysical Theory and Modeling-Michaelis-Menten Kinetics under Spatially Constrained Conditions: Application to Mibefradil Pharmacokinetics. K Kosmidis, V Karalis, P Argyrakis, P Macheras Biophysical Journal 87 (3), 1498-1506, 2004 | | 2004 |
